#LCSM Chat Topic 9/8: You’ve Been Diagnosed With Lung Cancer…Now What?
Our topic for the next #LCSM Chat on Thursday, September 8, 2016, at 5 PM Pacific (8 PM Eastern) is “You’ve Been Diagnosed with Lung Cancer…Now What?” Our moderator will be Laronica Conway (@louisianagirl91). Have you (or someone you know) been recently diagnosed with lung cancer? What happens next? Just getting past the shock of the diagnosis can be challenging and emotionally draining, but knowing the next steps can possibly help remove some of the uncertainty. This week we’ll open up the discussion and seek advice from health care providers and from… Read More
#LCSM Chat Topic 8/25: Pain and Lung Cancer Treatment: How Does it Affect You or Someone You Know?
Our topic for the next #LCSM Tweet Chat on Thursday, August 25th at 5 PM Pacific (8 PM Eastern) is “Pain and lung cancer treatment: How does it affect you or someone you know?” The moderator for this chat is Dr. David Tom Cooke (@DavidCookeMD) Advances in the care and treatment of individuals with lung cancer are appearing rapidly. With lung cancer screening we are finding earlier stage tumors. With immunotherapy and targeted therapy, we are finding effective treatments for patients with advanced and metastatic lung cancer. But during lung cancer interventions… Read More
#LCSM Chat Topic 8/11: Direct to Consumer (DTC) Advertising in Lung Cancer–Educating Patients or Oversimplifying to Sell?
by H. Jack West, MD For some patients, seeing a TV commercial featuring Opdivo (nivolumab) as a product for lung cancer that highlights its survival benefit was a welcome new development. These commercials have blanketed high profile TV telecasts that have often focused on cars, insurance, and new technology devices. But some people find direct to consumer advertising of medications, especially cancer drugs, to be distasteful and arguably harmful. With the lung cancer community now entering a new era of DTC advertising of treatments that encourage patients and caregivers to “ask your… Read More
#LCSM 
You must be logged in to post a comment.